团队共有研究生33人，其中硕士研究生23人，博士研究生18人，博士后2人（其中有8人是硕博连读）。其中7人获得国家奖学金，2人获得北京市优秀毕业生，2人获得直接攻读博士研究生资格。研究方向涉及肾移植免疫耐受、肾缺血再灌注损伤、泌尿系统肿瘤发生发展机制等， 在核心期刊上以第一作者和通讯作者发表学术论文104篇，其中72篇为SCI论文。共主持国家及省部级课题13项，其中国家自然科学基金3项，北京市自然科学基金2项，首都临床特色应用研究与成果推广课题2项。作为主编和主译编写和翻译书籍4部，参译和参编其它专著11部。

1.   IL-33诱导调节性巨噬细胞体系的建立及其在肾移植免疫耐受中的应用与机制研究——国家自然科学基金（面上项目）（82070764，第一负责人）

2.   TGF-β诱导MDSCs联合常用免疫抑制剂预防排斥反应及其机制研究——国家自然科学基金（面上项目）（81771720，第一负责人）

3.   IL-33促进中性粒细胞胞外诱捕网形成加重肾脏缺血再灌注损伤的分子机制研究——国家自然科学基金（面上项目）（82370752，第一负责人）

4.  Apelin通过增强足细胞自噬改善肾缺血再灌注损伤的分子机制研究——北京市自然科学基金（面上项目）（7252052，第一负责人）

5.  IL-33诱导的调节性巨噬细胞在肾移植免疫耐受中的细胞分子机制研究——北京市自然科学基金（面上项目）（7212040，第一负责人）

6.   GLP－1受体激动剂对肾移植术后新发糖尿病患者糖代谢及其并发症的疗效研究—前瞻性随机对照研究——首都临床特色应用研究与成果推广（Z221100007422029，第一负责人）

7.   术前新型标志物等多参数联合预测DCD供肾移植功能延迟恢复的临床应用研究——首都临床特色应用研究与成果推广（Z17110000101755 ，第一负责人）

8.   早期转换为低剂量钙调磷酸酶抑制剂联合西罗莫司对肾移植患者疗效和安全性的多中心随机对照临床研究——中华国际医学交流基金会专项基金项目（ChiCTR800017277，总负责人）

9.   GLP-1受体激动剂对肾移植术后新发糖尿病患者糖代谢及其并发症的影响—前瞻性随机对照研究——首都医科大学附属北京朝阳医院孵化项目（CYFH202203，第一负责人）

        在核心期刊上以第一作者和通讯作者发表学术论文104篇，其中72篇为SCI论文。主持国家自然科学基金面上项目3项，北京市自然科学基金等省部级课题10项。作为主编和主译编写和翻译书籍4部，参译和参编其它专著11部。以第一发明人获得实用新型专利1项。在与兄弟医院一起合作的科研项目——《肾脏移植免疫抑制个体化用药方案的建立与应用》也荣获2012年中华医学科技进步奖一等奖。2016年本人前往美国著名的Johns Hopkins医学院进行博士后深造，主要从事有关造血干细胞对于预防和治疗缺血再灌注损伤和移植肾慢性排斥反应方面的研究。相关的研究结果多次在世界器官移植大会（TTS），美国器官移植大会（ATC）和全国器官移植学术会议进行了大会发言以及会议交流。由于在科研及临床上的出色表现，本人于2008年入选北京市科技新星，2010年被评为北京市卫生系统高层次卫生技术人才，2013年人选北京市优秀人才。

（一）论文情况

1.   Qianchuan Tian , Zhaoqi Zhang , Liang Tan , Fan Yang , Yanan Xu , Yinan Guo , Dong Wei , Changhong Wu , Peng Cao , Jiawei Ji , Wei Wang (Corresponding author) , Xubiao Xie , Yong Zhao. Skin and heart allograft rejection solely by long-lived alloreactive TRM cells in skin of severe combined immunodeficient mice. Sci Adv. 2022 Jan 28;8(4):eabk0270. doi: 10.1126/sciadv.abk0270. Epub 2022 Jan 26. (IF:14.957)

2.   Wang K, Shen X, Wu J, Bi Q, Gao Z, Sun Z, Wang W*（Corresponding author）. Fibrogenesis-driven tumor progression in clear cell renal cell carcinoma: prognostic, therapeutic implications and the dual role of neuropilin-1. Cancer Cell Int. 2025 May 16;25(1):179. doi: 10.1186/s12935-025-03801-2.

3.   Wu J, Zhang F, Li Z, Gan L, Cao H, Cao H, Hao C, Sun Z, Wang W*（Corresponding author）. Multiple omics-based machine learning reveals specific macrophage sub-clusters in renal ischemia-reperfusion injury and constructs predictive models for transplant outcomes. Comput Biol Chem. 2025 Aug;117:108421. doi: 10.1016/j.compbiolchem.2025.108421. Epub 2025 Mar 11.

4.   Li Z, Wang Z, Liu Y, Yang L, Gu L, Li H, Wang W*（Corresponding author）. IVC treatment between primary and second TURBT may improve the prognosis of high-risk NMIBC patients receiving BCG treatment. Sci Rep. 2025 Feb 10;15(1):4874. doi: 10.1038/s41598-025-89008-x. Erratum in: Sci Rep. 2025 Apr 23;15(1):14163. doi: 10.1038/s41598-025-98177-8.

5.   Li Z, Wang Z, Wu J, Zhang F, Gan L, Wang W*（Corresponding author）, Li H, Gu L. Intravesical chemotherapy in BCG waiting period may prolong time to recurrence for high-risk NMIBC patients. BMC Cancer. 2025 Feb 14;25(1):268. doi: 10.1186/s12885-025-13705-z.

6.   Zhang JD, Xue XY, Zhang YF, Lin SQ, Sun ZJ, Yan LX, Zhang YG, Wang W*（Corresponding author）. IL-4 exerts beneficial anti-tumor effect dependent on a short-range manner. Cytokine. 2025 Jul;191:156950. doi: 10.1016/j.cyto.2025.156950.

7.   Zhang Y, Qiu X, Wu Z, Li Y, Shen X, Wu J, Cao P, Sun Z, Wang W*（Corresponding author）. Comprehensive analysis of the association between volatile organic compound pollutants and chronic kidney disease in hypertensive populations: insights from multi-omics approaches and identification of potential therapeutic targets. Environ Res. 2025 May 27;282:121966. doi: 10.1016/j.envres.2025.121966.

8.   Zheng X, Chen D, Wu J, Gao Z, Huang M, Fan C, Chang J, Liu Y, Zeng X, Wang W*（Corresponding author）. Apelin-13 inhibits ischemia-reperfusion mediated podocyte apoptosis by reducing m-TOR phosphorylation to enhance autophagy. FASEB J. 2025 Jan 31;39(2):e70319. doi: 10.1096/fj.202402850R. 

9.   Gan L, Wu J, Zhang F, Cao H, Li Z, Gao Z, Cao H, Sun Z*, Wang W*(Corresponding author). Laparoscopic versus robotic adrenalectomy: a systematic review and meta-analysis. J Endourol.

10. Wu Z, Li S, Li Y, Wang Z, Wang W* (Corresponding author). Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. Discover Oncology.

11. Cao H, Hao C, Zhang T, Zheng X, Gao Z, Wu J, Gan L, Liu Y, Zeng X, Wang W* (Corresponding author). Battle of the artificial intelligence: a comprehensive comparative analysis of DeepSeek and ChatGPT for urinary incontinence-related questions. Front. Public Health.

12. Wu J, Gan L, Shen X, Zhang F, Li Z, Cao H, Wang H, Sun Z, Qi L, Wang W*(Corresponding author). Multiple omics-based machine learning reveals peripheral blood immune cell landscape during acute rejection of kidney transplantation and constructs a precise non-invasive diagnostic strategy. Mamm Genome.

13. Haojun Wang # , Quanwei Zhou #, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang*（Corresponding author）. LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell Death Dis.2024 Feb 22;15(2):165.doi: 10.1038/s41419-024-06542-8. （IF：9.685）

14. Zejia Sun, Feilong Zhang, Zihao Gao, Jiyue Wu, Qing Bi, Xiang Zheng, Jiandong Zhang, Peng Cao, Wei Wang*（Corresponding author）. Liraglutide alleviates ferroptosis in renal ischemia reperfusion injury via inhibiting macrophage extracellular trap formation. Int Immunopharmacol. 2024 Dec;142:113258. doi: 10.1016/j.intimp.2024.113258. Epub 2024 Sep 27.（IF：4.800）

15. Dongshan Chen, Haoyuan Cao, Xiang Zheng, Haojun Wang, Zengchi Han, Wei Wang*(Corresponding author). Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target. BMC Cancer. 2024 Aug 19;24(1):1024. doi: 10.1186/s12885-024-12790-w. (IF: 3.4)

16. Yuqing Li, Jiandong Zhang, Xuemeng Qiu, Yifei Zhang, Jiyue Wu, Qing Bi, Zejia Sun*, Wei Wang*(Corresponding author). Diverse regulated cell death patterns and immune traits in kidney allograft with fibrosis: a prediction of renal allograft failure based on machine learning, single-nucleus RNA sequencing and molecular docking. Renal Failure. 2024 Dec 4;46(2):2435487. doi: 10.1080/0886022X.2024.2435487. (IF: 3.1)

17. Shen Xihao, Wu Jiyue, Zhang Feilong, Bi Qing, Sun Zejia, Wang Wei*(Corresponding Author). Deciphering the impact of senescence in kidney transplant rejection: An integrative machine learning and multi-omics analysis via bulk and single-cell RNA sequencing. PLoS One. 2024 Nov 27;19(11):e0312272. doi: 10.1371/journal.pone.0312272.(IF: 2.9)

18. Haojun Wang#, Wen Wen# , Mingxi Yao, Tongwang Yang, Dongshan Chen* and Wei Wang*（Corresponding author）. Deciphering the genomic insights into the coexistence of congenital scoliosis and congenital anomalies of the kidney and urinary tract. Front. Genet., 23 July 2024. DOI 10.3389/fgene.2024.1399604(IF: 2.8)

19. Jiyue Wu #, Feilong Zhang #, Xiang Zheng #, Dongshan Chen, Zhen Li, Qing Bi, Xuemeng Qiu, Zejia Sun, Wei Wang*（Corresponding author）. Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes. Sci Rep.2024 Jun 23;14(1):14431. doi: 10.1038/s41598-024-65198-8. (IF: 3.8)

20. Jiawan Wang #, Wei Wang #(co- first-author), Jiandong Zhang, Fei Xiao, Zeya Li, Pengfei Xu, Haozhou Wang, Heng Du, Siqi Liu, Huili Li, Xuan Zhang, Siqi Chen, Zeyu Gao, Sheng Wang, Jun Wang, Moshi Song . Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia-reperfusion in mice. Commun Biol. 2024 Aug 27;7(1):1054. (IF: 4.164)

21. Qing Bi, Ji‐Yue Wu, Xue‐Meng Qiu, Yu‐Qing Li, Yu‐Yao Yan, Ze‐Jia Sun, Wei Wang*（Corresponding author）. Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed graft function and renal allograft failure: a machine learning-based exploration in the framework of predictive, preventive, and personalized medicine. Epma Journal. 2023. (IF: 8.836)

22. Zheng X, Zhang W, Zhou H, Cao R, Shou Z, Zhang S, Cheng Y, Chen X, Ding C, Li N, Shi S, Zhou Q, Chen Q, Chen G, Chen Z, Zhou P, Hu X, Xue W, Zhang X, Na N, Wang W*（Corresponding author）. A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients. Chin Med J (Engl). 2023 Mar 5;136(5):607-609. doi: 10.1097/CM9.0000000000002604. PMID: 36921118; PMCID: PMC10106260. (IF: 6.100)

23. Cao H, Zhang J, Sun Z, Wu J, Hao C, Wang W*（Corresponding author）. Frailty in kidney transplant candidates and recipients: pathogenesis and intervention strategies. Chin Med J (Engl). 2023 May 5;136(9):1026-1036. doi: 10.1097/CM9.0000000000002312. PMID: 37052144; PMCID: PMC10228484. (IF: 6.100)

24. Qiu X, Bi Q, Wu J, Sun Z, Wang W*（Corresponding author）. Role of ferroptosis in fibrosis: From mechanism to potential therapy. Chin Med J (Engl). 2023 Sep 5. doi: 10.1097/CM9.0000000000002784. Epub ahead of print. PMID: 37668091. (IF: 6.100)

25. Linbin Hua, Jiyue Wu, Jiashu Ge, Xin Li, Bin You, Wei Wang*（Corresponding author） and Bin Hu*.  Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes. Frontiers in cell and developmental biology. 2023;11:1060086. (IF: 6.081)

26. Sun Z, Gao Z, Li X, Zheng X, Wang W*（Corresponding author）, Qiao P. Perfusate Neutrophil Gelatinase-Associated Lipocalin, Kidney Injury Molecular-1, Liver-Type Fatty Acid Binding Protein, and Interleukin-18 as Potential Biomarkers to Predict Delayed Graft Function and Long-Term Prognosis in Kidney Transplant Recipients: A Single-Center Retrospective Study. Med Sci Monit. 2023 Mar 4;29:e938758. doi: 10.12659/MSM.938758. PMID: 36869580; PMCID: PMC9993774. (IF:3.100)

27. Wang H, Yang T, Wu J, Chen D, Wang W*（Corresponding author）. Unveiling the Mystery of SUMO-activating enzyme subunit 1: A Groundbreaking Biomarker in the Early Detection and Advancement of Hepatocellular Carcinoma. Transplant Proc. 2023 May;55(4):945-951. doi: 10.1016/j.transproceed.2023.03.042. Epub 2023 May 24. PMID: 37236867. (IF:0.900)

28.  Jiyue Wu, Feilong Zhang, Xiang Zheng, Jiandong Zhang, Peng Cao, Zejia Sun, Wei Wang*（Corresponding author）Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes. Frontiers in Immunology. 2022;13. (IF: 8.786)

29. Jiyue Wu, Qing Bi, Xiang Zheng, Huawei Cao, Changzhen Hao, Zejia Sun, Wei Wang*（Corresponding author）. STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma. BMC Cancer. 2022;22(1):1204. doi: 10.1186/s12885-022-10313-z. (IF:4.638)

30. Feilong Zhang, Yuqing Li, Jiyue Wu, Jiandong Zhang, Peng Cao, Zejia Sun, Wei Wang*（Corresponding author）. The role of extracellular traps in ischemia reperfusion injury. Front Immunol. 2022;13:1022380. (IF: 8.786)

31. Peng Cao, Zejia Sun, Feilong Zhang, Jiandong Zhang, Xiang Zheng, Baozhong Yu, Yong Zhao, Wei Wang, Wei Wang*（Corresponding author）. TGF-b Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression 2022;13:919674. doi: 10.3389/fimmu.2022.919674. (IF: 8.786)

32. Zejia Sun, Zihao Gao, Jiyue Wu, Xiang Zheng, Shizhao Jing, Wei Wang*（Corresponding author）. MSC-Derived Extracellular Vesicles Activate Mitophagy to Alleviate Renal Ischemia/Reperfusion Injury via the miR-223-3p/NLRP3 Axis Stem Cells Int2022 May 20;2022:6852661. doi: 10.1155/2022/6852661.（IF：5.131）

33. Zejia Sun, Jiyue Wu, Qing Bi and Wei Wang*（Corresponding author）. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis. Stem Cell Research & Therapy (2022) 13:297.(IF :8.079)

34. Dongshan Chen, Chen Zhang, Yuanwei Zang, Wei Wang*（Corresponding author） and Jiandong Zhang. Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma. Front. Genet. 13:970900. doi: 10.3389/fgene.2022.970900.（IF：4.772）

35. Qing Bi, Ze-Jia Sun, Ji-Yue Wu, Wei Wang*（Corresponding author）. Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment. Front Oncol. 2022 Mar 17;12:868639. doi: 10.3389/fonc.2022.868639.（IF：6.244）

36. Qing Bi, Ji-Yue Wu, Xue-Meng Qiu, Jian-Dong Zhang, Ze-Jia Sun, Wei Wang*（Corresponding author）. Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis. J Immunol Res. 2022 Jun 13;2022:3128933. doi: 10.1155/2022/3128933.（IF：4.818）

37. Peng Cao, Ji-Yue Wu, Jian-Dong Zhang, Ze-Jia Sun, Xiang Zheng, Bao-Zhong Yu, Hao-Yuan Cao, Fei-Long Zhang, Zi-Hao Gao, Wei Wang*（Corresponding author）. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes. BMC Cancer. Jun 23 2022;22(1):691. doi:10.1186/s12885-022-09755-2. (IF: 4.638)

38. Cao H, Sun Z, Wu J, Hao C and Wang W*（Corresponding author）. Metastatic Clear Cell Renal Cell Carcinoma to Pancreas and Distant Organs 24 Years After Radical Nephrectomy: A Case Report and Literature Review. Front. Surg. 9:894272. doi: 10.3389/fsurg.2022.89427

39. Jiyue Wu, Zejia Sun, Qing Bi, Wei Wang（Corresponding author）.A ferroptosis-related genes model allows for prognosis and treatment stratification of clear cell renal cell carcinoma: a bioinformatics analysis and experimental verification. Front Oncol. 2022; e 2022 Jan 27. ;12:815223.doi: 10.3389/fonc.2022.815223

40. Jiawei Ji, Yuan Zhuang, Zhemin Lin, Yihang Jiang, Wei Wang (Corresponding author), Xiaodong Zhang. IFN γ induced MDSCs aggravate kidney ischemic-reperfusion injury by regulating innate immune cells. Nephron - Experimental Nephrology and Genetics. 2022;146(1):99-109. doi: 10.1159/000518876. Epub 2021 Sep 21.

41.  Peng Cao, Feilong Zhang, Jiandong Zhang, Xiang Zheng, Zejia Sun, Baozhong Yu, Wei Wang*. CYP3a5 Genetic Polymorphism in Chinese Population With Renal Transplantation: A Meta-Analysis Review. Transplant Proc. Apr 2022;54(3):638-644. doi:10.1016/j.transproceed.2021.10.031. (IF: 1.014)

42. Zhang L, Wang W (Co-first author), Liu L, Zhang Y, Zhang X. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha protects a fibrotic liver from partial hepatectomy-induced advanced liver injury through regulating cell cycle arrest. Basic Clin Pharmacol Toxicol. 2021 Nov 29. doi: 10.1111/bcpt.13697. Epub ahead of print. PMID: 34845850.

43. Xiang Zheng, Wei-Jie Zhang, Hua Zhou, Rong-Hua Cao, Zhang-Fei Shou, Shu-Wei Zhang, Ying Cheng, Xu-Chun Chen, Chen-Guang Ding, Zuo-Fu Tang, Ning Li, Shao-Hua Shi, Qiang Zhou, Qiu-Yuan Chen, Gang Chen, Zheng Chen, Pei-Jun Zhou, Xiao-Peng Hu, Xiao-Dong Zhang, Ning Na, Wei Wang （Corresponding author）. Study protocol: a randomized controlled trial to evaluate effificacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients.Chinese Medical Journal 2021;Vol(No) Received: 29-01-2021 DOI: 10.1097/CM9.0000000000001866

44. Feilong Zhang, Jiyue Wu, Zejia Sun, Dawei Xie, Xiaoyong Yang, Wei Wang (Corresponding author). Nephrogenic adenoma of the renal pelvis：a rare case report and review of the literature. Medicine(Baltimore). 2021, Aug 27;100(34):e27025. doi: 10.1097/MD.0000000000027025.

45. Changzhen Hao, Jiandong Zhang, Feilong Zhang, Jiyue Wu, Huawei Cao, Wei Wang (Corresponding author). Mitochondrial DNA may act as a biomarker to predict donor-kidney quality. Clin Transplant. 2021, Aug 26; e14469. doi: 10.1111/ctr.14469.

46. Jiandong Zhang, Chen Zhang, Peng Cao, Xiang Zheng, Baozhong Yu, Haoyuan Cao, Zihao Gao, Feilong Zhang, Jiyuan Wu, Huawei Cao, Changzhen Hao, Zejia Sun, Wei Wang（Corresponding author）. A zinc finger protein gene signature enables bladder cancer treatment stratification. Aging (Albany NY). 2021 May 7;13(9):13023-13038. doi: 10.18632/aging.202984.

47. Jiyue Wu, Feilong Zhang, Jiandong Zhang, Zejia Sun, Changzhen Hao, Huawei Cao, Wei Wang（Corresponding author）. A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma. Technol Cancer Res Treat. 2021; Jan-Dec;20:15330338211027923. doi: 10.1177/15330338211027923.

48. Baozhong Yu, Xiang Zhang, Zejia Sun, Peng Cao, Jiandong Zhang, Wei Wang （Corresponding author）. IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival. Front Genet. 2021 Feb 15;12:599952. doi: 10.3389/fgene.2021.599952.

49. Baozhong Yu, Xiang Zhang, Zejia Sun, Peng Cao, Jiandong Zheng, Zihao Gao, Haoyuan Cao, Feilong Zhang , Wei Wang （Corresponding author）. The safety and efficacy of doxazosin in medical expulsion therapy for distal ureteric calculi: A meta-analysis. PLoS One. 2021 Jan 25;16(1):e0245741. doi: 10.1371/journal.pone.0245741

50. Zhang F, Zhang J, Cao P, Sun Z, Wang W （Corresponding author）. The characteristics of regulatory macrophages and their roles in transplantation. Int Immunopharmacol. 2021 Jan 5;91:107322. doi: 10.1016/j.intimp.2020.107322.

51. Jiyue Wu, Feilong Zhang, Jiandong Zhang, Zejia Sun, Wei Wang（Corresponding author）. Advances of miRNAs in kidney graft injury. Transplant Rev (Orlando). 2021, Jan;35(1):100591. doi: 10.1016/j.trre.2020.100591.  PMID: 33309915 Review.

52. Baozhong Yu , Jiandong Zhang , Zejia Sun , Peng Cao , Xiang Zheng , Zihao Gao , Haoyuan Cao , Feilong Zhang , Wei Wang （Corresponding author）. Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis. Medicine (Baltimore). 2021 Jan 8;100(1):e24257. doi: 10.1097/MD.0000000000024257.

53. Haoyuan Cao , Jiandong Zhang , Wei Wang（Corresponding author）. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma. Technol Cancer Res Treat.  2020; 5;11(11):3207-3215. doi: 10.7150/jca.37285.1533033820936682.

54. Peng Cao#, Zejia Sun, Chang Feng, Jiandong Zhang, Feilong Zhang, Wei Wang（Corresponding author）, Yong Zhao. Myeloid-derived suppressor cells in transplantation tolerance induction. Int. Immunopharmacol. 2020;83:106421. 

55. Li Y, Wang W（Co-first author）, Yang F, Xu Y, Feng C, Zhao Y.The regulatory roles of neutrophils in adaptive immunity. Cell Commun Signal. 2019 ;17(1):147

56. Ze-Jia Sun, Xiao-Peng Hu, Bo-Han Fan, Wei Wang（Corresponding author）.Epstein-Barr virus-positive post-transplant lymphoproliferative disordepresenting as hematochezia and enterobrosis in renal transplant recipients in China: A report of two cases.World J Clin Cases 2019;7(24): 4334-4341

57. Fan Yang，Yang Li，Weilong Zou，Yanan Xu，Hao Wang，Wei Wang（Corresponding author），Yong Zhao. Adoptive transfer of IFN-γ-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway. Inflammation Research. 2019, 68(7),545-555

58. Sun Z, Li X, Zheng X, Cao P, Yu B, Wang W（Corresponding author）. Stromal cell-derived factor-1/CXC chemokine receptor 4 axis in injury repair and renal transplantation. J Int Med Res. 2019; 10(3): 5426–5440

59. J.-F. Cai, W. Wang（Corresponding author）, W. Hao, Z.-J. Sun, L.-L. Su, X. Li, X. Zheng, and X.-D. Zhang. Meta-analysis of Early Versus Late Ureteric Stent Removal After Kidney Transplantation. Transplantation Proceedings 2018 ; 50(10):3411-3415.

60. Du, X., Z.J. Sun, L.L. Su, and X.D. Zhang，W. Wang（Corresponding author）. Meta-analysis on the Safety and Efficacy of the Reperfusion Use of a Single High Dose of Anti–T-Lymphocyte Globulin Fresenius in Kidney Transplantation. Transplantation Proceedings 2016 ; 48(6):2017-2022.

61. Sun ZJ, Du X, Su LL, Zhang XD, Wang Y, Ren L, Wang W（Corresponding author）. Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in China. Chinese Medical Journal. 2016 ; 129(11) : 1379-1381

62. Sun ZJ, Du X, Su LL, Zhang XD, Wang W（Corresponding author）.Efficacy and Safety of Basiliximab Versus Daclizumab in Kidney Transplantation: A Meta-Analysis. Transplant Proc. 2015;47(8):2439-2445.

63. Wang W, Feng SJ, Li H, Zhang XD, Wang SX. Correlation of Lower Concentrations of Hydrogen Sulfide with Activation of Protein Kinase CβII in Uremic Accelerated Atherosclerosis Patients. Chin Med J (Engl). 2015;128(11):1465-1470.

64. Li H, Feng SJ, Su LL, Wang W（Corresponding author）, Zhang XD, Wang SX. Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy. Chin Med J (Engl). 2015;128(10):1351-1357.

65. Li H, Li X, Feng S, Zhang G, Wang Wei（Corresponding author）, Wang S, Sleep disorders and its related risk factors in patients undergoing chronicperitoneal dialysis. Chin Med J (Engl). 2014;127(7):1289-1293.

66. WANG Wei, Zhang XN, Yin H, Li XB, Hu XP, Liu H, Wang Y, Zhang XD. Effects of Bailing capsules for renal transplant recipients: a retrospective clinical study. Chin Med J (Engl). 2013,126(10):1895-1899.

67. Liang X, WANG Wei（Corresponding author）, Li H. Water and sodium restriction on cardiovascular disease in young chronic hemodialysis patients. 2013,126(9):1667-1672.

68. WANG Wei, YIN Hang, LI Xiaobei, HU Xiaopeng, YANG Xiaoyong, LIU Hang, REN Liang, WANG Yong and ZHANG Xiaodong. A Retrospective Comparison of the Efficacy and Safety in Kidney Transplant Recipients with Basiliximab and anti-thymocyte globulin. Chin Med J (Engl). 2012; 125(6):1135-1140.

69. WANG Wei, TIAN Hui, YIN Hang, LIU Hang and ZHANG Xiaodong. Attitudes toward organ donation in China. Chin Med J (Engl). 2012; 125(6):56-62.

70. WANG Wei, LI Xiaobei, YIN Hang, YANG Xiaoyong, LIU Hang, REN Liang, HU Xiaopeng, WANG Yong and ZHANG Xiaodong. Factors affecting the long-term renal allograft survival. Chin Med J (Engl). 2011, 124(8):1850-1853.

71. WANG Wei, LI Xiaobei, YANG Xiaoyong, and ZHANG Xiaodong. Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection. Chin Med J (Engl). 2011, 124(12):1775-1778.

72. WANG Wei, Zhang Xiaodong, GUAN Delin, LU Yueping, MA Linlin, HU Xiaopeng, ZHANG Peng,WANG Yong and CHEN Xiao. Relationship between MDR1 polymorphism and blood concentration of cyclosporine A. Chin Med J (Engl). 2005,24:2097-2100.

73. 姚明希，张建东，曹浩原，李雨清，王玮（通讯作者）. 免疫检查点抑制剂联合应用在肾细胞癌治疗中的研究进展[J]. 中华医学杂志,2024,104(46)：4267-4273.DOI:10.3760/cma.j.cn112137-20240529-01219.

74. 吴极岳，孙泽家，毕青，邱雪萌，王玮（通讯作者）. 基于生物信息学和机器学习算法构建肾移植术后抗体介导排斥反应的诊断预测模型[J]. 中华器官移植杂志,2024,45(10):718-727. DOI:10.3760/cma.j.cn421203-20230928-00109.

75. 曹华伟，张建东，王玮（通讯作者），胥青芝. 肾移植受者衰弱患病情况及相关因素分析. 中华医学杂志，2023，103（20）：1531-1537.

76. 王浩钧,孙泽家, 王玮（通讯作者）.移植肾纤维化的诊断和治疗优化方案[J/OL].器官移植:1-7[2023-12-21].

77. 曹华伟，孙泽家，王玮. 肾透明细胞癌根治术后24年胰腺等多处器官转移一例. 中国临床案例成果数据库，2022，04(01):E092-E092. DOI:10.3760/cma.j.cmcr.2022.e00092

78. 张飞龙，王玮（通讯作者）.细胞免疫治疗在肾移植中的临床转化与前景. 中华医学杂志，2021，101（26）：2099-2102.

79. 郁堡中，孙泽家，王玮（通讯作者）.肾移植术后妊娠及生育相关研究进展. 中华器官移植杂志，2021，42（03）：183-185.  

80. 郑翔 谷丽 郎韧 孙兵 李绪言 王玮（通讯作者）.多囊肾合并多囊肝患者肾移植后肝囊肿反复感染行肝移植一例并文献复习. 中华器官移植杂志, 2020,41(08) : 470-473. 

81. 蔡继飞,王玮（通讯作者）,任亮,孙泽家,李馨,郑翔,苏路路,张小东. 供者血液新型生物标志物在评估移植肾功能恢复延迟中的应用. 中华器官移植杂志, 2020,41(02) : 94-98. DOI: 10.3760/cma.j.issn.0254-1785.2020.02.008

82. 孙泽家，张小东，张希诺，曹鹏，李馨，郑翔，郁堡中，王玮（通讯作者）. 肾移植术后新发供者特异性抗体对受者预后影响的回顾性研究. 中华器官移植杂志. 2019; 40(8), 457-461

83. 张飞龙, 孙泽家, 曹鹏, 王玮（通讯作者）. 调节性巨噬细胞在移植免疫中的研究进展； 中华医学杂志, 2019; 99(34), 2713-2716

84. 郁堡中，孙泽家，蒋一航，王玮（通讯作者）.肾移植术后糖尿病的危险因素及研究进展.实用器官移植电子杂志，2019，7（3）：226-230.

85. 孙泽家，张小东，任亮，杨晓勇，蔡继飞，李馨，郑翔，王玮（通讯作者）。肌酐下降率预测心脏死亡供体肾移植术后移植肾功能延迟恢复。中华医学杂志2018, 98(1):36-41.

86. 杜鑫，孙泽家，蔡继飞，李馨，刘航，任亮，张小东，王玮（通讯作者）。高致敏二次肾移植患者术前应用硼替佐米行脱敏治疗1例报告及文献复习。器官移植，2017，8（5）；365-370.

87. 蒋一航，王玮（通讯作者），胡小鹏，王伟，尹航，刘航，任亮，杨晓勇，范博涵，张小东。 稳定期肾移植受者吗替麦考酚酯暴露量研究的药代学和药效学试验。中华器官移植杂志 2015, 36(4）；217-224.

88. 王玮，蒋一航，胡小鹏，尹航，刘航，任亮，王伟，胡小鹏，范博涵，张小东。NGAL与Cys c对于肾移植术后早期肾功能恢复的预测作用。中华医学杂志2015, 95(2):112-115.

89. 王 玮（通讯作者），苏路路 张小东。PBL 联合EBL 教学法在泌尿外科临床教学中的应用。中国病案，2015, 16(4):80-82.

90. 张希诺，李寒，王玮（通讯作者），张征，尹航，邱葵，刘航，王伟，胡小鹏，张小东。肾移植受者口服马替麦考酚酯和麦考酚钠肠溶片的临床研究。中华器官移植杂志 2014, 35(8)；464-468.

91. 王玮, 尹航,李晓北,杨晓勇,任亮,刘航,张鹏,胡小鹏,王勇,张小东. 肾移植术后并发双侧字体肾盂和输尿管移行细胞癌16例. 中华器官移植杂志 2011,8:474-476.

92. 田惠忠,王玮（通讯作者）,刘航,张小东. 肾移植术后并发肺结核的早期诊治与预防. 中华健康管理学杂志2011, 5; 345-349.

93. 王玮, 尹航,胡小鹏,李晓北,杨晓勇,任亮,王勇,张小东. 生理盐水替代HTK保存液保存活体供肾的临床研究. 器官移植杂志 2011,5:269-272.

94. 王玮,李晓北,尹航,刘航,任亮,杨晓勇,胡小鹏. 肾移植术后合并卡氏肺囊虫肺炎的早期诊断与治疗. 中华器官移植杂志 2010,4:227-230.

95. 王玮,李晓北,丁毅,尹航,刘航,胡小鹏,王勇,张小东. 肾移植术后侵袭性肺曲霉菌病16例诊治分析. 中华医学杂志2010,2:110-112.

96. 王玮,刘航,尹航,李晓北,杨晓勇,任亮,胡小鹏,王勇,张小东. 免疫吸附在高致敏肾移植受者中的应用. 中华医学杂志2010,90:2532-2535.

97. 王玮,李寒,张小东. 谈泌尿外科实习医师的带教体会. 首都医科大学学报2010:455

98. 王玮,张小东,李晓北,胡小鹏,尹航,刘航,任亮,王勇. 移植肾动脉狭窄的诊治20例报告. 中华器官移植杂志2009,11:692-693.

99. 王玮,张小东. 多药耐药基因多态性与肾移植术后免疫抑制剂应用（下）.国际移植与血液净化杂志, 2008,6:19-22.

100.     王玮,张小东. 多药耐药基因多态性与肾移植术后免疫抑制剂应用（上）.国际移植与血液净化杂志, 2008,6:14-18.

101.     王玮,张小东,丁洁,马麟麟,胡小鹏,王勇,陈晓,管德林. 肾移植患者的多药耐药基因外显子26基因型与术后他克莫司用量的关系. 中华器官移植杂志2006,12:728-730.

102.     王玮,张小东,马麟麟,王勇,胡小鹏,陈晓,杨勇. 多囊肾患者肾移植术后的临床效果. 临床泌尿外科杂志, 2006, 5:331-333.

103.     王玮,管德林,张小东,马麟麟,陈晓,胡小鹏,赵勇. 多药耐药基因多态性与免疫抑制剂应用关系的研究. 中华泌尿外科杂志2006,Suppl:89-91.

104.     王玮,张小东,马麟麟,胡小鹏,张鹏,王勇.吕月平,管德林. 肾移植中他克莫司的血药浓度与多药耐药基因多态性的关系. 中华医学杂志2005,46:3277-3281.

（二）课题情况

1.   IL-33诱导调节性巨噬细胞体系的建立及其在肾移植免疫耐受中的应用与机制研究——国家自然科学基金（面上项目）（82070764，第一负责人）

2.   TGF-β诱导MDSCs联合常用免疫抑制剂预防排斥反应及其机制研究——国家自然科学基金（面上项目）（81771720，第一负责人）

3.   IL-33促进中性粒细胞胞外诱捕网形成加重肾脏缺血再灌注损伤的分子机制研究——国家自然科学基金（面上项目）（82370752，第一负责人）

4.  Apelin通过增强足细胞自噬改善肾缺血再灌注损伤的分子机制研究——北京市自然科学基金（面上项目）（7252052，第一负责人）

5.  IL-33诱导的调节性巨噬细胞在肾移植免疫耐受中的细胞分子机制研究——北京市自然科学基金（面上项目）（7212040，第一负责人）

6.   GLP－1受体激动剂对肾移植术后新发糖尿病患者糖代谢及其并发症的疗效研究—前瞻性随机对照研究——首都临床特色应用研究与成果推广（Z221100007422029，第一负责人）

7.   术前新型标志物等多参数联合预测DCD供肾移植功能延迟恢复的临床应用研究——首都临床特色应用研究与成果推广（Z17110000101755 ，第一负责人）

8.   早期转换为低剂量钙调磷酸酶抑制剂联合西罗莫司对肾移植患者疗效和安全性的多中心随机对照临床研究——中华国际医学交流基金会专项基金项目（ChiCTR800017277，总负责人）

9.   GLP-1受体激动剂对肾移植术后新发糖尿病患者糖代谢及其并发症的影响—前瞻性随机对照研究——首都医科大学附属北京朝阳医院孵化项目（CYFH202203，第一负责人）

（三）专著情况

1.   活体肾脏捐献评估、护理与随访(副主译)               中国科学技术出版社2022

2.   急性肾损伤与血液净化                              人民卫生出版社 2018

3.   肾移植临床用药                                    人民卫生出版社 2018